SCYNEXIS, Inc. - Common Stock (NQ:SCYX)

3.770 -0.090 (-2.33%)

Delayed Quote Updated: 4:00 PM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about SCYNEXIS, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

On Tuesday, there are stocks with unusual volume. Let's take a look. ↗

September 29, 2026

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 26, 2026

Gainers Biohaven (NYSE:BHVN) shares increased by 16.5% to $16.75 during Wednesday's regular session. The market value of their outstanding shares is at $2.1 billion. SCYNEXIS (NASDAQ:SCYX) stock...

Via Benzinga

Top movers in Friday's session ↗

July 31, 2026

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 31, 2026

Gainers Replimune Group (NASDAQ:REPL) stock rose 96.1% to $10.61 during Friday's regular session. SCYNEXIS (NASDAQ:SCYX) stock moved upwards by 22.54% to $4.57. The market value of their outstanding...

Via Benzinga

Wondering what's happening in today's after-hours session? ↗

May 25, 2026

Via Chartmill

Should you consider SCYNEXIS INC (NASDAQ:SCYX) for growth investing? ↗

May 20, 2024

Exploring SCYNEXIS INC (NASDAQ:SCYX)'s growth characteristics.

Via Chartmill

SCYNEXIS INC (NASDAQ:SCYX) Combines Minervini Trend Template with High-Growth Momentum Fundamentals ↗

April 13, 2026

SCYNEXIS (SCYX) meets both high-growth fundamental criteria and strict technical trend rules, showing strong earnings momentum and a confirmed bullish chart pattern.

Via Chartmill

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 20, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 02, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 30, 2025

Via Benzinga

Here are the top movers in Tuesday's session. ↗

September 30, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 30, 2025

Via Benzinga

These stocks are moving in today's session ↗

September 30, 2025

Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

Tuesday's session: gap up and gap down stocks ↗

September 30, 2025

The market is filled with gapping stocks in Tuesday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

Stay updated with the stocks that are on the move in today's pre-market session. ↗

September 30, 2025

The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

The market is filled with gapping stocks in Friday's session. ↗

May 16, 2025

Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

Via Chartmill

SCYX Stock Earnings: SCYNEXIS Misses EPS, Misses Revenue for Q2 2024 ↗

August 09, 2024

SCYX stock results show that SCYNEXIS missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

July 23, 2024

Pre-market stock movers are a hot topic that traders are going to want to know about and we have all of the latest news on Tuesday morning!

Via InvestorPlace

3 Stocks Under $10 With the Potential for Massive Gains ↗

July 22, 2024

Discover the growth potential of top small-cap stocks in the consumer finance, healthcare equipment and pharmaceutical industries.

Via InvestorPlace

3 Dirt-Cheap Drug Developers With Blockbuster Potential ↗

July 11, 2024

These are three of the best cheap drug developer stocks for investors to keep an eye as their growth could be imminent.

Via InvestorPlace

7 Undervalued Biotech Stocks to Buy for Big-Time Returns ↗

July 01, 2024

The broader healthcare sector enjoys a powerfully relevant narrative. Undervalued biotech stocks makes the case even more attractive.

Via InvestorPlace

Hidden Gems: 3 Under-$10 Stocks Poised for 500% Growth by 2025 ↗

May 31, 2024

Read here about the top under-$10 growth stocks primed for financial success through strategic partnerships and innovative product offerings.

Via InvestorPlace

3 Stocks Under $10 With Mammoth Growth Prospects ↗

May 23, 2024

Learn more about the growth stocks under $10 with progressive fundamentals in the healthcare and technology sectors.

Via InvestorPlace

SCYX Stock Earnings: SCYNEXIS Beats EPS, Misses Revenue for Q1 2024 ↗

May 08, 2024

SCYX stock results show that SCYNEXIS beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

SCYX Stock Earnings: SCYNEXIS Misses EPS, Beats Revenue for Q4 2023 ↗

March 28, 2024

SCYX stock results show that SCYNEXIS missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

5 Value Stocks To Watch In The Healthcare Sector ↗

January 29, 2024

Via Benzinga

A Look Into Healthcare Sector Value Stocks ↗

January 08, 2024

Via Benzinga

Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket ↗

January 04, 2024

Shares of Resources Connection, Inc. (NASDAQ: RGP) rose sharply in pre-market trading following better-than-expected results for its second quarter.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 03, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 02, 2024

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.